Envista (NYSE:NVST) Upgraded by Mizuho to “Hold” Rating

by · The Markets Daily

Mizuho upgraded shares of Envista (NYSE:NVST – Free Report) from a strong sell rating to a hold rating in a research note published on Tuesday morning,Zacks.com reports.

A number of other equities research analysts have also recently issued reports on the stock. Wall Street Zen cut shares of Envista from a “strong-buy” rating to a “buy” rating in a research report on Sunday. Weiss Ratings reissued a “sell (d)” rating on shares of Envista in a report on Monday, December 29th. Barclays initiated coverage on shares of Envista in a research report on Monday, December 8th. They issued an “overweight” rating and a $24.00 price target for the company. Stifel Nicolaus set a $25.00 price target on Envista in a research report on Thursday, October 30th. Finally, JPMorgan Chase & Co. raised their price objective on Envista from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Tuesday, December 16th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $22.15.

Get Our Latest Report on NVST

Envista Price Performance

Envista stock opened at $24.33 on Tuesday. The company has a market capitalization of $4.00 billion, a price-to-earnings ratio of 270.31, a PEG ratio of 1.13 and a beta of 0.99. The company has a current ratio of 2.37, a quick ratio of 2.02 and a debt-to-equity ratio of 0.47. Envista has a 12 month low of $14.22 and a 12 month high of $25.41. The stock’s 50 day moving average is $21.67 and its 200-day moving average is $20.85.

Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. Envista had a return on equity of 5.90% and a net margin of 0.58%.The business had revenue of $669.90 million during the quarter, compared to the consensus estimate of $639.49 million. During the same period in the previous year, the company posted $0.12 EPS. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. Equities research analysts expect that Envista will post 1 EPS for the current year.

Hedge Funds Weigh In On Envista

A number of institutional investors have recently added to or reduced their stakes in NVST. Farther Finance Advisors LLC boosted its position in Envista by 317.6% in the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after buying an additional 1,026 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in shares of Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after acquiring an additional 949 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in Envista by 378.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after acquiring an additional 1,909 shares during the last quarter. Finally, SJS Investment Consulting Inc. increased its holdings in Envista by 10,356.5% in the 3rd quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock worth $49,000 after purchasing an additional 2,382 shares in the last quarter.

Envista Company Profile

(Get Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

See Also